{
    "table_name": "EBI_CHEMBL.DRUG_MECHANISM_30",
    "table_fullname": "EBI_CHEMBL.EBI_CHEMBL.DRUG_MECHANISM_30",
    "column_names": [
        "molregno",
        "mechanism_of_action",
        "direct_interaction",
        "site_id",
        "mechanism_comment",
        "disease_efficacy",
        "variant_id",
        "action_type",
        "tid",
        "record_id",
        "selectivity_comment",
        "binding_site_comment",
        "molecular_mechanism",
        "mec_id"
    ],
    "column_types": [
        "NUMBER",
        "TEXT",
        "NUMBER",
        "NUMBER",
        "TEXT",
        "NUMBER",
        "NUMBER",
        "TEXT",
        "NUMBER",
        "NUMBER",
        "TEXT",
        "TEXT",
        "NUMBER",
        "NUMBER"
    ],
    "description": [
        "Molregno for the drug (foreign key to molecule_dictionary table)",
        " Description of the mechanism of action e.g., 'Phosphodiesterase 5 inhibitor'",
        "Flag to show whether the molecule is believed to interact directly with the target (1 = yes, 0 = no)",
        "Binding site for the drug within the target (where known) - foreign key to binding_sites table",
        "Additional comments regarding the mechanism of action",
        "Flag to show whether the target assigned is believed to play a role in the efficacy of the drug in the indication(s) for which it is approved (1 = yes, 0 = no)",
        "None",
        "Type of action of the drug on the target e.g., agonist/antagonist etc (foreign key to action_type table)",
        "Target associated with this mechanism of action (foreign key to target_dictionary table)",
        "Record_id for the drug (foreign key to compound_records table)",
        "Additional comments regarding the selectivity of the drug",
        "Additional comments regarding the binding site of the drug",
        "Flag to show whether the mechanism of action describes the molecular target of the drug, rather than a higher-level physiological mechanism e.g., vasodilator (1 = yes, 0 = no)",
        "Primary key for each drug mechanism of action"
    ],
    "sample_rows": [
        {
            "mec_id": 2105,
            "record_id": 3130881,
            "molregno": 1336998,
            "mechanism_of_action": "Unknown",
            "tid": null,
            "site_id": null,
            "action_type": null,
            "direct_interaction": 1,
            "molecular_mechanism": 1,
            "disease_efficacy": 1,
            "mechanism_comment": null,
            "selectivity_comment": null,
            "binding_site_comment": null,
            "variant_id": null
        },
        {
            "mec_id": 2130,
            "record_id": 1344002,
            "molregno": 1017790,
            "mechanism_of_action": "Unknown",
            "tid": null,
            "site_id": null,
            "action_type": null,
            "direct_interaction": 1,
            "molecular_mechanism": 1,
            "disease_efficacy": 1,
            "mechanism_comment": "Antitussive drug; probable action in the CNS cough centre",
            "selectivity_comment": null,
            "binding_site_comment": null,
            "variant_id": null
        },
        {
            "mec_id": 2131,
            "record_id": 1344781,
            "molregno": 674662,
            "mechanism_of_action": "Unknown",
            "tid": null,
            "site_id": null,
            "action_type": null,
            "direct_interaction": 1,
            "molecular_mechanism": 1,
            "disease_efficacy": 1,
            "mechanism_comment": "Mode of action not fully understood; it seems to increase beta-oxidation, inhibit acyl-CoA:1,2-diacylglycerol acyltransferase (EC 2.3.1.20), decreas lipogenesis in the liver, and increase plasma lipoprotein lipase activity",
            "selectivity_comment": null,
            "binding_site_comment": null,
            "variant_id": null
        },
        {
            "mec_id": 2132,
            "record_id": 1679372,
            "molregno": 1369605,
            "mechanism_of_action": "Unknown",
            "tid": null,
            "site_id": null,
            "action_type": null,
            "direct_interaction": 1,
            "molecular_mechanism": 1,
            "disease_efficacy": 1,
            "mechanism_comment": "Mode of action not fully understood; it seems to increase beta-oxidation, inhibit acyl-CoA:1,2-diacylglycerol acyltransferase (EC 2.3.1.20), decreas lipogenesis in the liver, and increase plasma lipoprotein lipase activity",
            "selectivity_comment": null,
            "binding_site_comment": null,
            "variant_id": null
        },
        {
            "mec_id": 2134,
            "record_id": 1641024,
            "molregno": 88317,
            "mechanism_of_action": "Unknown",
            "tid": null,
            "site_id": null,
            "action_type": null,
            "direct_interaction": 1,
            "molecular_mechanism": 1,
            "disease_efficacy": 1,
            "mechanism_comment": null,
            "selectivity_comment": null,
            "binding_site_comment": null,
            "variant_id": null
        }
    ]
}